Previcox is a drug owned by BOEHRINGER LNGELHEIM ANIMAL HEALTH USA, INC. It is protected by 6 US drug patents filed from 2018 to 2019. All patents have expired. Details of Previcox’s patents and their expiration are given below.
Exclusivity Information
Previcox holds 2 exclusivitys out of which 2 have expired. Details of Previcox's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCE | Jul 21, 2009 |
| NCI | Dec 18, 2010 |
Previcox Petitions
Details of Previcox's suitability petitions are listed below.
| Petitioner | Action | Date of Action | Description |
|---|---|---|---|
 | |||
| Noble Pharma, LLC | Approved | NA | |
About Previcox
Previcox is a drug
owned by BOEHRINGER LNGELHEIM ANIMAL HEALTH USA, INC.
Previcox uses
Firocoxib as the active
ingredient.
Active Ingredient:
Previcox uses
Firocoxib as the active ingredient.
Check out other Drugs and Companies using
Firocoxib ingredient.